The Oncology Drug Development Landscape
Download this critical review to receive a data-driven analysis of the Oncology drug & trial landscape. Put yourself at the forefront of innovation with unparalleled insights into the dynamic and fast-paced world of Oncology drug development with Beacon Oncology.
This Report Contains
Key small molecule, biological and advanced therapy drug modalities being investigated as treatments for Oncology disease indications.
The top Oncology targets and disease indications being investigated pre-clinically and clinically.
Oncology assets with the highest clinical trial activity in 2024.
You May Also Be Interested In...
Oncology: 2024 Landscape Review
ADCs in the Oncology Landscape Infographic
Find Out More
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape. Each dataset features proprietary, hyper-relevant search and filtering tailored to specific modalities, in-depth data, plus additional market insight curated by our subject matter experts. Beacon is here to support you in making these decisions with confidence through our encompassing database solution.
With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
Any questions? Get in touch
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
